KLP Kapitalforvaltning AS purchased a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 45,202 shares of the company's stock, valued at approximately $3,128,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Versant Capital Management Inc raised its holdings in shares of Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after purchasing an additional 335 shares in the last quarter. Venturi Wealth Management LLC raised its stake in Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after acquiring an additional 569 shares during the last quarter. Quent Capital LLC raised its stake in shares of Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after purchasing an additional 323 shares during the last quarter. Smartleaf Asset Management LLC grew its position in Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after buying an additional 143 shares during the last quarter. Finally, City State Bank acquired a new stake in shares of Henry Schein in the 4th quarter worth $55,000. Hedge funds and other institutional investors own 96.62% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on the company. UBS Group lowered their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Wells Fargo & Company started coverage on Henry Schein in a research note on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target on the stock. Jefferies Financial Group increased their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. Mizuho began coverage on Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price objective for the company. Finally, Barrington Research reissued an "outperform" rating and set a $90.00 price objective on shares of Henry Schein in a research note on Wednesday, February 26th. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $81.10.
Get Our Latest Research Report on HSIC
Insider Activity at Henry Schein
In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.
Henry Schein Stock Down 1.1 %
Shares of HSIC traded down $0.78 during midday trading on Friday, reaching $68.62. 1,028,798 shares of the company were exchanged, compared to its average volume of 1,573,330. The stock has a 50-day moving average price of $74.62 and a 200-day moving average price of $72.68. The company has a market cap of $8.52 billion, a price-to-earnings ratio of 28.24, a P/E/G ratio of 2.13 and a beta of 0.90. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.49.
Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same quarter in the prior year, the business earned $0.66 earnings per share. The firm's revenue was up 5.8% on a year-over-year basis. Research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.
Henry Schein Profile
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Stories

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.